Isomorphic Labs IsoDDE vs Insilico Medicine
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Isomorphic Labs IsoDDE
DeepMind's AI Drug Design Engine that doubles AlphaFold 3 accuracy in...
Visit
|
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 8.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Enterprise |
| Free tier | None — no free or academic tier publicly available | Chemistry42 cloud offers academic/startup access tiers; contact required |
| Paid from | Enterprise partnership only; deals structured around R&D milestones (not per-seat or API) | Enterprise licensing; upfront deals from $10M milestone to $115M (Lilly) |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | Not publicly disclosed; access limited to pharma partnership cohort | 13 of top 20 global pharma cos; 18.3% YoY subscription growth (2025) |
| Founded | 2021 | 2014 |
| Maker | Alphabet Inc. (via Google DeepMind spinoff) | Insilico Medicine (independent; HKEX: 3696) |
| Verdict | Isomorphic Labs IsoDDE represents a genuine scientific leap in AI-driven drug design — its 50% accuracy on the hardest protein-ligand prediction benchmark, outperformance of physics-based gold standards in binding affini... |
Insilico Medicine holds a lead no other AI-native drug company currently matches: a molecule it designed from scratch has reached Phase III, with published peer-reviewed efficacy data behind it. The Pharma.AI stack — Pan... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.